Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
09/2003
09/16/2003CA2102782C 2-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents
09/12/2003WO2003074541A1 Processes for the synthesis of 5’-deoxy-5’ chloroadenosine and 5’-deoxy-5’methylthioadenosine
09/12/2003WO2003073989A2 Nucleoside 5'-monophosphate mimics and their prodrugs
09/12/2003CA2754415A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2754041A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2477795A1 Nucleoside 5'-monophosphate mimics and their prodrugs
09/12/2003CA2477729A1 Processes for the synthesis of 5'-deoxy-5' chloroadenosine and 5'-deoxy-5'methylthioadenosine
09/11/2003US20030171330 Antibacterial compound
09/11/2003US20030171321 Immunostimulatory oligodeoxynucleotides
09/11/2003US20030170872 Mutagenic nucleoside analogs for the treatment of viral disease
09/11/2003US20030170831 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
09/11/2003US20030170689 Determination of nucleic acid sequence pattern
09/11/2003US20030170680 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
09/10/2003EP1341412A1 Indolocarbazole anticancer agents and methods of using them
09/10/2003EP1090023B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
09/10/2003EP1090021B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
09/10/2003EP0747389B1 3'-substituted nucleoside derivatives
09/10/2003CN1440751A Matrix metal proteinase and tumor necrosis inhibitor
09/09/2003US6617445 Asymmetric benzoxanthene dye for use as signaling tools in nucleotide sequence analysis
09/09/2003US6617439 Adenine with a thioether substituent; use as enzyme inhibitors; modulates conversion into nucleosides
09/09/2003US6617438 Nucleic acid of given formula; ribozyme able to cleave RNA of HER2 gene; use as anticarcinogenic agent
09/09/2003US6617437 Modified oligonucleotide of given formula; useful in diagnostics and therapeutics
09/09/2003US6617315 Therapeutic compounds
09/09/2003US6617136 Comprises polymerase or a ligase and near-infrared diiminium dye or cyanine dye; amplification
09/09/2003CA2079413C Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
09/04/2003WO2003072757A2 Nucleotide mimics and their prodrugs
09/04/2003WO2003072586A2 Methods of producing phosphitylated compounds
09/04/2003WO2003072067A2 Compositions and methods for treating epithelial and retinal tissue diseases
09/04/2003WO2003072066A2 Compositions and methods for the treatment of glaucoma and ocular hypertension
09/04/2003WO2003051298A3 Preparation of intermediates useful in the synthesis of antiviral nucleosides
09/04/2003US20030166896 Polynucleotide containing phosphoramidite group
09/04/2003US20030166606 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
09/04/2003US20030166582 Aryl fused azapolycyclic compounds
09/04/2003US20030165969 Non-nucleotide containing enzymatic nucleic acid
09/04/2003US20030165961 UV excitable energy transfer reagents
09/04/2003US20030165922 System, method and apparatus for transgenic and targeted mutagenesis screening
09/04/2003US20030165900 Ribozymes; antisense oligonucleotides; hammerhead/hairpin motifs
09/04/2003US20030165880 For detecting single nucleotide polymorphisms (SNPs) in diploid organisms using modified nucleotides/residues
09/04/2003US20030165849 Methods and reagents for introducing a sulfhydryl group into the 5'-terminus of RNA
09/04/2003US20030165837 Method for screening DNA binding
09/04/2003CA2477741A1 Nucleotide mimics and their prodrugs
09/04/2003CA2477039A1 Methods of producing phosphitylated compounds
09/03/2003EP1339798A2 Sulfonated diarylrhodamine dyes
09/03/2003CN1440292A Pyrido[2,3-D] rimidine and pyrimido[4,5-D] pyrimidine nucleosides
09/03/2003CN1439644A Preparation of slafudine crystal I by composite solvent
09/02/2003US6613926 Perchloramido phosphonyl reagents and analogs thereof
09/02/2003US6613896 Method of producing tiazofurin and other C-nucleosides
09/02/2003US6613894 Bonding the nucleoside to a solid support, deprotecting using an acid, reacting with a nucleoside phosphoramidite; oxidizing and coupling a biomolecule to the product
09/02/2003US6613367 Complete nutrition of infants products are characterized by the type and amount of protein and carbohydrate and the increased levels of folic acid, vitamin B6 and vitamin B12 or their functional equivalents. These products improve feelings
09/02/2003US6613345 Conjugates of sodium channel blockers and methods of using the same
08/2003
08/28/2003WO2003070739A1 Partial and full agonists of a1 adenosine receptors
08/28/2003WO2003070174A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
08/28/2003WO2003051881B1 Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies
08/28/2003WO2003002587A3 Phosphoramide containing nucleic acid-based compounds and libraries as antivirals
08/28/2003WO2002088382A3 Method for analysing nucleic acid chains
08/28/2003WO2002083720A3 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
08/28/2003US20030162992 Preparation of intermediates useful in the synthesis of antiviral nucleosides
08/28/2003US20030162957 Protected deoxyadenosines and deoxyguanosines
08/28/2003US20030162749 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
08/28/2003US20030162743 Matrix metalloproteinase and tumor necrosis factor inhibitors
08/28/2003US20030162742 Oral administration of methyl-4-(3-(9-6-aminopurin-2-yl)) prop-2-ynyl)cyclohexane-carboxylate, having A2A adenosine receptor antagonist activity
08/28/2003US20030162739 Antisense molecules and method of controlling expression of gene function by using the same
08/28/2003US20030162738 Antigenic composition comprising a polycationic peptide and inosine and cytosine
08/28/2003US20030162213 Terminal-phosphate-labeled nucleotides and methods of use
08/28/2003US20030162199 Polymerase chain reactions; by-product inhibition
08/28/2003US20030162198 Medical diagnosis; complexing to Dna; calibration
08/28/2003CA2476423A1 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
08/27/2003EP1338282A1 Uridine derivatives as Matrix Metalloproteinase (MMP) and Tumor Necrosis Factor (TNF) inhibitors for the treatment of cancer
08/27/2003EP1337541A2 Massive parallel method for decoding DNA and RNA
08/27/2003EP1169046B1 Pulmonary delivery of protonated/acidified nucleic acids
08/27/2003CN1439016A 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
08/27/2003CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base
08/26/2003US6610842 Removing hydroxyl protecting group from compound of given formula and treating with another compound; wide range of diagnostic and therapeutic uses
08/26/2003US6610841 Nucleic acid ligand covalently bonded via a hydrolyzable junctional ester bond to a drug component; sustained-release; effective drug delivery system with reduced toxicity
08/26/2003US6610837 Preparation of an oligonucleotide compound of given formula by reacting with given compounds, followed by oxidation or sulfurization
08/26/2003US6610727 Antitumor agents
08/26/2003US6610665 2-(purin-9-yl)-tetrahydrofuran-3, 4-diol derivatives
08/26/2003US6610663 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
08/26/2003US6610660 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates
08/26/2003US6610502 2-amino-3-(2-( alpha -mannopyranosyl)indole-3-yl)propionic acid; to a method for testing a biological function by quantitating 2- amino-3-(2-( alpha -mannopyranosyl)indole-3-yl)propionic acid in a collected
08/26/2003US6610492 The present invention is directed to novel base-modified nucleotides and methods for their use in the preparation and cleavage of modified polynucleotides.
08/26/2003US6610482 Sequencing, fingerprinting and mapping biological macromolecules, typically biological polymers. The methods make use of a plurality of sequence specific recognition reagents which can also be used for classification of
08/25/2003CA2419773A1 Matrix metalloproteinase and tumor necrosis factor inhibitors
08/21/2003WO2003068796A1 4’-c-cyano-2’-deoxypurine nucleosides
08/21/2003WO2003068795A1 Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereof
08/21/2003WO2003068794A1 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof
08/21/2003WO2003068244A1 Methods of inhibiting orthopoxvirus replication with nucleoside compounds
08/21/2003WO2003068164A2 Dosing regimen for gemcitabine hcv therapy
08/21/2003WO2003068162A2 Modified fluorinated nucleoside analogues
08/21/2003WO2003051897B1 Nucleoside analog libraries and compounds
08/21/2003WO2003039450A3 Improvements in or relating to inhibition of viruses
08/21/2003WO2002094844A3 Antiviral nucleosides
08/21/2003WO2002044425A3 Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
08/21/2003WO2002033128A3 Multiplex quantification of nucleic acids in diseased cells
08/21/2003WO2002008446A9 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries
08/21/2003US20030158149 Administering a nucleoside or a nucleoside analog, such as (5'-fluoro-5-methyl-beta-arabinofuranosyl-uridine) or salt or prodrug that suppresses the expression of hepatitis B surface or preS1 antigen in the host 100-fold
08/21/2003US20030158147 Method for treating pain
08/21/2003US20030158146 Chemical compounds
08/21/2003US20030158145 6-((2,2- diphenylethyl)amino)-9-(N-ethyl- beta -D-ribofuranosyluronamide)-N--(2-(N'-(1-(2-pyridyl)-4 -piperidyl)ureido)ethyl)-9H-purine-2-carboxamide
08/21/2003US20030157731 Analyte assay using particulate labels
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 201